Headlines
-
NSW Labor pledges scope expansion
Wednesday | Dec 7 2022MOVES to expand pharmacists' scope of practice will go ahead in NSW regardless of which of the major parties forms government after the State election next Mar.
-
Incident reports rise with bivalent vax
Wednesday | Dec 7 2022PHARMACIST immunisers are being urged to review all vaccination processes before administering a shot, following an increase in incident reports to professional indemnity insurer, Pharmaceutical Defence Limited (PDL).
-
SA to investigate pharmacist UTI trial
Monday | Dec 5 2022SOUTH Australian could be the next jurisdiction to implement a trial of a pharmacy-based urinary tract infection (UTI) treatment program, pending the findings of a Parliamentary inquiry this week.
-
Dooley lands SHPA’s top honour
Monday | Dec 5 2022FORMER Society of Hospital Pharmacists of Australia (SHPA) President, Professor Michael Dooley, has been honoured with the organisations highest honour, the Fred J Boyd Award.
-
MediSecure lands deals
Monday | Dec 5 2022PHARMACY software providers, Corum Group and Z Software are set to adopt MediSecure as their preferred Prescription Delivery Service (PDS).
-
SHPA’s best days lie ahead: Simpson
Friday | Dec 2 2022TASMANIAN leadership of the Society of Hospital Pharmacists of Australia (SHPA) will continue with Tom Simpson, elected to succeed Peter Fowler, as the organisation's new National President.
-
Prescribing trials threaten healthcare
Friday | Dec 2 2022STATE Governments are being urged to reconsider planned pharmacist prescribing trials, with the Australian Medical Association (AMA) warning they will create a two-tier health system.
-
Star Pharmacy celebrates winners
Friday | Dec 2 2022THE Star Pharmacy Group recently held their 2022 Centre of Excellence Conference and Awards Night at scenic Adelaide Oval.
-
Bill to limit pharmacists
Friday | Dec 2 2022LEGISLATION banning lobby groups from making donations of more than $3,000 per electoral term, will limit pharmacists' from supporting political causes, Queensland Senator, James McGrath, says.
-
LGP takes step towards OTC CBD
Thursday | Dec 1 2022MEDICINAL cannabis company, Little Green Pharma (LGP), could be the first to deliver a Schedule 3 product to the Australian market, after securing ethics approval for its Phase III SleepWell Study.
